Cannabis companies in both Canada and the US are beginning to feel the heat, as not only are they facing more lawsuits from disgruntled investors, but their directors & officers (D&O) insurance costs have increased as a result.
Reuters reports that cannabis companies such as Medmen Enterprises, Canopy Growth, CannTrust Holdings, Aphria, and Columbia Care have been on the receiving end of shareholder litigation, which has accused the company leaders of false claims, failing to act in shareholders’ interests, and attempts to defraud investors.
You've reached your limit - Register for free now for unlimited access
To read the full story, and get unlimited access to Insurance Business website content, just register for free now. GET STARTED HERE
Already a website member? Log in below.